tiprankstipranks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Income Statement

Compare
393 Followers

Phathom Pharmaceuticals Income Statement

Last quarter (Q4 2024), Phathom Pharmaceuticals's total revenue was $29.66M, an increase of 4249.56% from the same quarter last year. In Q4, Phathom Pharmaceuticals's net income was $-74.45M. See Phathom Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 55.25M$ 682.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 47.28M$ 515.00K$ -620.00K$ -521.00K$ -300.00K
Operating Expenses
$ 324.75M$ 167.83M$ 172.44M$ 135.08M$ 125.67M
Depreciation and Amortization
$ 795.00K$ 575.00K$ 620.00K$ 521.00K$ 300.00K
EBITDA
$ -261.52M$ -159.05M$ -171.82M$ -134.56M$ -124.19M
Operating Income
$ -277.47M$ -167.31M$ -172.44M$ -135.08M$ -125.67M
Other Income/Expenses
$ -56.86M$ -34.28M$ -25.28M$ -8.80M$ -3.40M
Pretax Income
$ -334.33M$ -201.59M$ -197.72M$ -143.88M$ -129.07M
Net Income
$ -334.33M$ -201.59M$ -223.01M$ -148.09M$ -133.32M
Per Share Metrics
Basic EPS
$ -5.29$ -3.93$ -5.70$ -4.00$ -4.01
Diluted EPS
$ -5.29$ -3.93$ -5.70$ -4.00$ -4.01
Weighted Average Shares Outstanding
63.18M 51.29M 39.12M 37.00M 33.23M
Weighted Average Shares Outstanding (Diluted)
63.18M 51.29M 39.12M 37.00M 33.23M
Currency in USD

Phathom Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis